- Home
- RNA vs GVA Comparison
RNA vs GVA Comparison
Compare RNA & GVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- GVA
- Stock Information
- Founded
- RNA 2012
- GVA 1922
- Country
- RNA United States
- GVA United States
- Employees
- RNA N/A
- GVA N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- GVA Military/Government/Technical
- Sector
- RNA Health Care
- GVA Industrials
- Exchange
- RNA Nasdaq
- GVA Nasdaq
- Market Cap
- RNA 4.0B
- GVA 4.8B
- IPO Year
- RNA 2020
- GVA 1990
- Fundamental
- Price
- RNA $48.44
- GVA $106.90
- Analyst Decision
- RNA Strong Buy
- GVA Strong Sell
- Analyst Count
- RNA 17
- GVA 1
- Target Price
- RNA $69.53
- GVA $76.00
- AVG Volume (30 Days)
- RNA 3.4M
- GVA 823.7K
- Earning Date
- RNA 11-06-2025
- GVA 10-30-2025
- Dividend Yield
- RNA N/A
- GVA 0.48%
- EPS Growth
- RNA N/A
- GVA 70.18
- EPS
- RNA N/A
- GVA 3.11
- Revenue
- RNA $10,729,000.00
- GVA $4,078,324,000.00
- Revenue This Year
- RNA N/A
- GVA $12.76
- Revenue Next Year
- RNA $108.74
- GVA $9.12
- P/E Ratio
- RNA N/A
- GVA $34.53
- Revenue Growth
- RNA 1.23
- GVA 7.17
- 52 Week Low
- RNA $21.51
- GVA $69.08
- 52 Week High
- RNA $56.00
- GVA $112.16
- Technical
- Relative Strength Index (RSI)
- RNA 60.32
- GVA 45.78
- Support Level
- RNA $38.94
- GVA $105.62
- Resistance Level
- RNA $47.96
- GVA $110.67
- Average True Range (ATR)
- RNA 2.19
- GVA 2.10
- MACD
- RNA 0.54
- GVA -0.48
- Stochastic Oscillator
- RNA 97.67
- GVA 22.82
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About GVA Granite Construction Incorporated
Granite Construction Inc engages in the construction and development of various infrastructure projects on behalf of public and private clients in the United States. It focuses on heavy civil infrastructure projects, including roads, highways, transit facilities, airports, bridges, and other infrastructure projects. In addition, the company performs site preparation and infrastructure services for residential development, energy development, and other facilities. The majority of revenue is derived from the company's Construction operating segment, with the remainder derived from its Materials segment.